查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614052

藥物注射系統市場：按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Drug Infusion Systems Market by Product Type (Infusion Pump, IV Disposable), Application (Diabetes, Gastrointestinal Diseases, Oncology), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥物注射系統市值為226.1億美元，預計2024年將達到240.1億美元，複合年成長率為6.67%，到2030年將達到355.5億美元。

藥物輸注系統是醫療設備，用於以受控方式將含有藥物和營養物質的液體直接輸送到患者的循環系統中。輸液幫浦等醫療設備在醫院、門診診所、居家醫療機構等場所至關重要。這些系統的需求源於精確的藥物輸送，這對於化療、麻醉和糖尿病管理等治療至關重要。最終用途包括腫瘤學、小兒科、疼痛管理和慢性病等多種醫學領域，凸顯了其多功能性。

主要市場統計
基準年[2023] 226.1億美元
預測年份 [2024] 240.1億美元
預測年份 [2030] 355.5億美元
複合年成長率（%） 6.67%

藥物輸注系統市場的成長主要受到需要長期治療的慢性病盛行率上升、輸注系統技術進步以及家庭醫療保健日益增多等因素的影響。此外，快速成長的老年人口以及相關的醫療複雜性也推動了需求。潛在的商機包括將智慧技術和人工智慧整合到輸液泵中，以提高準確性和患者安全。投資研發以開發可攜式且經濟高效的輸液解決方案的公司將在這個充滿活力的市場環境中受益匪淺。

相反，阻礙市場成長的因素包括阻礙產品核可的嚴格監管要求、與先進輸液系統相關的高成本以及用藥錯誤和設備故障的風險。在用於遠端監控輸液系統的無線通訊技術、改進使用者介面設計以最大限度地減少人為錯誤以及符合永續性的輸液設備的生物分解性材料等領域正在取得創新和進步，看來這項研究將取得成果。

鑑於市場的競爭和演變，企業應注重策略夥伴關係關係，透過適應性強的定價策略提高產品的可及性，並致力於持續創新。透過解決限制並利用技術進步，公司可以在藥物注射系統領域獲得穩固的市場地位。

市場動態：快速發展的藥物注射系統市場的關鍵市場洞察

供需的動態交互作用正在改變藥物注射系統市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 癌症發生率增加和對化療輸注幫浦的需求
    • 輸液幫浦的採用率增加
    • 對高效、準確的給藥系統的需求不斷增加並轉向家庭醫療保健
  • 市場限制因素
    • 採購和安裝的初始成本較高
  • 市場機會
    • 擴大物聯網和人工智慧在藥物傳輸技術中的個人化醫療的整合
    • 加大藥物注射系統的投資與研發力度
  • 市場挑戰
    • 在網路威脅日益嚴重的情況下確保輸液系統的安全性和有效性

波特五力：駕馭藥物注射系統市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物注射系統市場的外部影響

外部宏觀環境因素在塑造藥物注射系統市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥物注射系統市場的競爭狀況

對藥物注射系統市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣給藥系統市場供應商績效評估

FPNV定位矩陣是評估藥物注射系統市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃藥物注射系統市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對藥物注射系統市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症發生率增加以及化療輸注幫浦的需求
      • 增加輸液幫浦的引入
      • 對高效、準確的給藥系統的需求不斷成長以及向家庭醫療保健的轉變
    • 抑制因素
      • 採購和安裝的初始成本較高
    • 機會
      • 擴大物聯網和人工智慧在藥物傳輸技術中的個人化醫療的整合
      • 加大藥物注射系統的投資與研發力度
    • 任務
      • 在網路威脅日益嚴重的情況下確保輸液系統的安全性和有效性
  • 市場區隔分析
    • 產品類型：對慢性病的持續關注正在增加一次性靜脈拋棄式的使用。
    • 應用：大量使用藥物輸注系統以維持最佳血糖值並最大限度地減少糖尿病相關併發症
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥物注射系統市場：依產品類型

  • 點滴幫浦
  • 拋棄式

第7章藥物注射系統市場：依應用分類

  • 糖尿病
  • 消化系統疾病
  • 腫瘤學
  • 小兒科

第8章藥物注射系統市場：依最終使用者分類

  • 居家護理
  • 醫院
  • 專科診所

第9章美洲藥物注射系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥物注射系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲注射系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 費森尤斯·卡比 (Fresenius Kabi) 與梅奧診所 (Mayo Clinic) 簽署 Evenix 輸液系統協議
    • Insulet 為具有可調警報限值和Bolus洩漏警報功能的輸液幫浦系統申請了專利
    • Eitan Medical推出雲端基礎的輸液管理平台
  • 戰略分析和建議

公司名單

  • AKAS Infusions
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson, and Company
  • Debiotech SA
  • Eitan Medical
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Halyard Health, Inc.
  • ICU Medical Inc.
  • Insulet Corporation
  • Intera Oncology Inc.
  • IRADIMED CORPORATION
  • Ivenix Inc.
  • Medtronic Plc
  • Micrel Medical Devices SA
  • Microport Scientific Corporation
  • MOOG, Inc.
  • Promecon GmbH
  • SINO MDT
  • Smiths Group plc
  • Tandem Diabetes Care, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-F97DD5A7D582

The Drug Infusion Systems Market was valued at USD 22.61 billion in 2023, expected to reach USD 24.01 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 35.55 billion by 2030.

Drug infusion systems are medical devices used to deliver fluids, including medications and nutrients, directly into a patient's circulatory system in a controlled manner. They include devices like infusion pumps, which are essential in settings such as hospitals, outpatient clinics, and home care. The necessity of these systems arises from their precision in medication delivery, which is critical for treatments such as chemotherapy, anesthesia, and diabetes management. In terms of end use, these systems find applications in various medical fields including oncology, pediatrics, pain management, and chronic diseases, highlighting their versatile scope.

KEY MARKET STATISTICS
Base Year [2023] USD 22.61 billion
Estimated Year [2024] USD 24.01 billion
Forecast Year [2030] USD 35.55 billion
CAGR (%) 6.67%

Market growth for drug infusion systems is primarily influenced by factors like the rising incidence of chronic diseases necessitating long-term treatment, technological advancements in infusion systems, and an increasing shift towards home healthcare. Additionally, the burgeoning geriatric population, with its associated medical complexities, is amplifying demand. Potential opportunities include the integration of smart technologies and artificial intelligence in infusion pumps to enhance precision and patient safety. Firms investing in R&D to develop portable and cost-effective infusion solutions stand to benefit greatly in this dynamic market environment.

Conversely, factors limiting market growth include strict regulatory requirements that can stymie product approvals, high costs associated with advanced infusion systems, and the risk of medication errors or device malfunctions. Innovation and research will be fruitful in areas such as wireless communication technologies for remote monitoring of infusion systems, improvements in user interface design to minimize human error, and biodegradable material for infusion devices to align with sustainability efforts.

Considering the competitive and evolving nature of the market, companies should focus on strategic partnerships, enhance product accessibility through adaptable pricing strategies, and engage in continuous technological innovation. By addressing the limitations and leveraging technological advancements, businesses can secure a robust market position in the drug infusion systems sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Infusion Systems Market

The Drug Infusion Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of cancer and the need for chemotherapy infusion pumps
    • Increasing adoption of infusion pumps
    • Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
  • Market Restraints
    • High initial cost of procurement and installation
  • Market Opportunities
    • Growing integration of IoT and AI for personalized medicine in drug delivery technologies
    • Increasing investments and R&D in drug infusion system
  • Market Challenges
    • Ensuring safety and efficacy of infusion systems amid rising cyber threats

Porter's Five Forces: A Strategic Tool for Navigating the Drug Infusion Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Infusion Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Infusion Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Infusion Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Infusion Systems Market

A detailed market share analysis in the Drug Infusion Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Infusion Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Infusion Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Infusion Systems Market

A strategic analysis of the Drug Infusion Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Infusion Systems Market, highlighting leading vendors and their innovative profiles. These include AKAS Infusions, B. Braun SE, Baxter International, Inc., Becton, Dickinson, and Company, Debiotech S.A., Eitan Medical, Flowonix Medical Inc., Fresenius Kabi AG, Fresenius SE & Co. KGaA, Halyard Health, Inc., ICU Medical Inc., Insulet Corporation, Intera Oncology Inc., IRADIMED CORPORATION, Ivenix Inc., Medtronic Plc, Micrel Medical Devices SA, Microport Scientific Corporation, MOOG, Inc., Promecon GmbH, SINO MDT, Smiths Group plc, Tandem Diabetes Care, Inc., Teleflex Incorporated, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Drug Infusion Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Infusion Pump and IV Disposable.
  • Based on Application, market is studied across Diabetes, Gastrointestinal Diseases, Oncology, and Pediatrics.
  • Based on End-user, market is studied across Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of cancer and the need for chemotherapy infusion pumps
      • 5.1.1.2. Increasing adoption of infusion pumps
      • 5.1.1.3. Rising demand for efficient and precise drug delivery systems and a shift toward home healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost of procurement and installation
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing integration of IoT and AI for personalized medicine in drug delivery technologies
      • 5.1.3.2. Increasing investments and R&D in drug infusion system
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring safety and efficacy of infusion systems amid rising cyber threats
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Increasing use of IV disposables owing to the ongoing concerns regarding chronic diseases
    • 5.2.2. Application: Extensive use of drug infusion systems to maintain optimal blood glucose levels and minimize diabetes-related complications
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Infusion Systems Market, by Product Type

  • 6.1. Introduction
  • 6.2. Infusion Pump
  • 6.3. IV Disposable

7. Drug Infusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Diabetes
  • 7.3. Gastrointestinal Diseases
  • 7.4. Oncology
  • 7.5. Pediatrics

8. Drug Infusion Systems Market, by End-user

  • 8.1. Introduction
  • 8.2. Homecare
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Drug Infusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Infusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Infusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Fresenius Kabi, Mayo Clinic Ink Deal On Ivenix Infusion System
    • 12.3.2. Insulet Files Patent On Infusion Pump System With Adjustable Alarm Limits And Missed Bolus Alarm
    • 12.3.3. Eitan Medical Launched Cloud-Based Infusion Management Platform
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AKAS Infusions
  • 2. B. Braun SE
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson, and Company
  • 5. Debiotech S.A.
  • 6. Eitan Medical
  • 7. Flowonix Medical Inc.
  • 8. Fresenius Kabi AG
  • 9. Fresenius SE & Co. KGaA
  • 10. Halyard Health, Inc.
  • 11. ICU Medical Inc.
  • 12. Insulet Corporation
  • 13. Intera Oncology Inc.
  • 14. IRADIMED CORPORATION
  • 15. Ivenix Inc.
  • 16. Medtronic Plc
  • 17. Micrel Medical Devices SA
  • 18. Microport Scientific Corporation
  • 19. MOOG, Inc.
  • 20. Promecon GmbH
  • 21. SINO MDT
  • 22. Smiths Group plc
  • 23. Tandem Diabetes Care, Inc.
  • 24. Teleflex Incorporated
  • 25. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. DRUG INFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG INFUSION SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG INFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG INFUSION SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY INFUSION PUMP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY IV DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG INFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG INFUSION SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. DRUG INFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DRUG INFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023